In patients with protein C and protein S deficiency, when warfarin therapy is started there is a more rapid fall in concentration of protein C (antigen and activity) than the other vitamin K ...

Background: A potential drug interaction exists between oral corticosteroids and warfarin, but there is limited documentation. Objective: To evaluate the potential drug interaction between oral ...

AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.

The Los Angeles Chargers are riding high under first-year coach Jim Harbaugh. They're 7-3 and in contention to make the playoffs. Everybody wants to interview the league's hottest team, 4-1 at ...

To underpin this with a real example, Seiter outlines the case of a new anticoagulant agent entering a market dominated by the older drug warfarin. The pharma client had approached launch with the ...